Market Overview

Benzinga's Top Pre-Market Gainers

Related INFI
Mid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop
Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Estimates
Related GRFS
FDA Approves Use Of Zika Virus Blood Screener From Hologic And Grifols
Hologic And Grifols Get FDA Approval For Procleix Zika Virus Assay

ExactTarget (NYSE: ET) added 53.74% to $33.87 in the pre-market session after (NYSE: CRM) announced its plans to buy ExactTarget for $2.34 billion.

Infinity Pharmaceuticals (NASDAQ: INFI) soared 5.85% to $17.37 in the pre-market trading. Infinity shares have jumped 38.60% over the past 52 weeks, while the S&P 500 index has gained 27.61% in the same period.

Grifols SA (NASDAQ: GRFS) moved up 5.13% to $28.10 in the pre-market session. Grifols' trailing-twelve-month operating margin is 25.54%.

General Motors Co (NYSE: GM) surged 2.70% to $35.35 in the pre-market session. GM will replace H. J. Heinz Co (NYSE: HNZ) in the S&P 500 on Thursday.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (CRM + ET)

View Comments and Join the Discussion!